baber/WOPTO huggingface dataset:
Patent DK-1562449-T3 (DK)
Inventor: LINES THOMAS CHRISTIAN
IPC: A23L33/15
Filed: 2003-10-23
Granted: 2011-06-06
Abstract: The invention relates to a composition that contains quercetin, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, caffeine, epigallocatechin gallate, epicatechin, epicatechin gallate, epigallocatechin, and polypheron E.
Patent DK-1486313-T3 (DK)
Inventor: TRAUTWEIN HERBERT
IPC: B29C35/16
Filed: 2004-06-08
Granted: 2006-03-27
Abstract: The mold, for deep drawing containers from a thermoplastic film web (7), has an upper (1) and a lower (2) section, with the mold insert (5) at the lower section. The upper section has a hold-down plate (14) for each mold unit, with a sliding stretch former (15). In the extended position of the stretch former, a seal (39) is between the stretch former or a trailing barrier piston and a drilling (19) in the hold-down plate. The seal lies in a groove (38) at the stretch former or the piston. The groove is linked to a compressed air supply (41) through drillings (37), to apply pressure on the seal against the drilling through the hold-down plate.
Patent DK-1495700-T3 (DK)
IPC: A44B13/00
Filed: 2004-07-02
Granted: 2008-01-28
Abstract: The eyelet is assembled of an insertion ring (5) and a clamping ring (10). The insertion ring (5) is designed as a saucer-shaped outer segment with an outwardly curved conical extension (8,11) which is pushed through the hole in the curtain. A slightly elastic second element (10) in the shape of a spring ring with a groove (27) surrounding its upper surface and a narrow lateral gap (13) is pushed over the extension (8, 11) into a matching groove (9, 12, 20) and is secured by a projection (21) protruding from its inner surface engaging with a matching opening (24) at the outer surface of the extension (8, 11). The ring (10) is additionally held by short spikes (19) located at its lower side and can be released by pressing a lateral element (25).
Patent DK-1661907-T3 (DK)
Inventor: CHEN YUSONG
IPC: C07K14/47
Filed: 2004-02-23
Granted: 2012-05-07
Abstract: The present invention relates to a cardio myopeptidin which is isolated from the hearts of non-human healthy mammals. The molecular weight of the cardio myopeptidin is less than 10000 Dalton, the peptide content thereof being 75%~90%, and the free amino acid content 6% ~ 15%, the ribonucleic acid content less than 2%, the deoxyribonucleic acid content less than 7.5%. The present invention further provides a method of producing the cardio myopeptidin and the use thereof in producing pharmaceuticals for treating cardiac disorders, specifically the use in producing pharmaceuticals for treating myocardial ischemic and reperfusion injury; the cardio myopeptidin of the present invention can work directly on myocytes, promoting the repair of injuries caused by various reasons, and providing a new way to relieve ischemic and reperfusion injury, and to promot the repair of injuried myocardium.
Patent DK-1627589-T3 (DK)
Inventor: BRUNTNER EUGEN
IPC: A47L9/19
Filed: 2005-08-16
Granted: 2008-11-24
Abstract: The vacuum cleaner has a closable air inlet (9) in the suction hose connector for equalizing the pressure between the inside (10) and outside (6) of the dust bag.
Patent DK-1789177-T3 (DK)
Inventor: FOUARGE LOUIS
IPC: B01J8/00
Filed: 2005-06-28
Granted: 2008-03-31
Abstract: The present invention discloses a slurry loop reactor having at least two loops (1,2) and comprising a by-pass line (11) connecting two points (12,13) of the same loop reactor by an alternate route having a different transit time than that of the main route, said by-pass line also collecting the growing polymer of a first loop reactor (1) and sending said growing polymer to an entry point (13) in a second reactor (2).
Patent DK-1928345-T3 (DK)
Inventor: KAHDEMANN STEFFEN
IPC: A61C8/00
Filed: 2006-09-27
Granted: 2011-09-05
Abstract: The present invention relates in general to the field of implant dentistry, namely to the design of a two-part medicinal device made of biocompatible ceramics, wherein said two-part medicinal device provides a basis for a crown or superstructure, which is easy to handle by a dentist. More precisely, the present invention relates to a two-part medicinal device comprising an implant part (1) and an abutment (12), wherein the prosthetic connection of both parts is provided by an internal connection (4a, 15a, 4b, 15b), which provides a secure connection between both parts.
Patent DK-1839792-T3 (DK)
Inventor: KULLMANN JOERG DR
IPC: B23D61/04
Filed: 2007-03-24
Granted: 2011-01-10
Abstract: The blade (1) has chip formation surface (7) welded at the joining area (5) with the projection (3) at the base (2). The projection has a laminar chip breaker (8) at the base. The projection is turned to chip formation surface arranged at the element (4) of the chip breaker turning into the projection of the base. The blade has smaller even divisions.
Patent DK-2069604-T3 (DK)
Inventor: CRAWFORD ALEXANDER CHARLES
IPC: E21B19/00
Filed: 2007-10-04
Granted: 2012-04-02
Abstract: Apparatus and a method for handling an elongate member such as a cable between two points has a support line extending between the points, and winch mechanisms and wrapping devices at each of the points, to permit the elongate member to transit between the two points in a wrapped bundle that is supported mechanically against damage and deviation from a controlled path between the points, and to permit the bundle to be unwrapped at the second point for further manipulation of the elongate member. The invention is particularly useful in raising and lowering a load, towing, and also handling service cables, tubes, pipes, hoses or other elongate lines that are connected between two points. A preferred embodiment is described for the subsea deployment of wireline and the deployment of signal and power cables to subsea wells.
Patent DK-2089008-T3 (DK)
Inventor: KELLAWAY IAN WALTER
IPC: A61K9/14
Filed: 2007-10-31
Granted: 2011-10-24
Abstract: A formulation suitable for delivery from a pressurised metered dose inhaler comprises a hydrofluoroalkane liquid, which is pharmaceutically acceptable, for instance HFA 134a or HFA 227, a drug to be delivered to the lung which is insoluble in the hydrofluoroalkane, the drug being in particulate form in the composition, further containing a suspension stabiliser which is a non-toxic essential oil miscible with the hydrofluoroalkane liquid at room temperature. The essential oil is preferably one having some amphiphilic property, such as a ketone or aldehyde compound. Insulin may be formulated for inhalation.
Patent DK-2017356-T3 (DK)
Inventor: BECKER MICHAEL M
IPC: C12Q1/68
Filed: 2007-06-06
Granted: 2012-01-30
Abstract: A pre-amplification reaction mixture for selective amplification of one or more target nucleic acid sequences, said reaction mixture comprising: a tagged oligonucleotide comprising first and second regions, said first region comprising a target hybridizing sequence hybridized to a target region contained at a 3'-end of one or more target nucleic acid sequences present in said reaction mixture and said second region comprising a tag sequence situated 5' to said target hybridizing sequence; a first oligonucleotide comprising a hybridizing sequence which hybridizes to a 3'-end of the complement of one or more of said target nucleic acid sequences; and a second oligonucleotide comprising a hybridizing sequence which hybridizes to the complement of said tag sequence, wherein said reaction mixture is substantially free of an active form of said tagged oligonucleotide which is not hybridized to said target region contained in said one or more target nucleic acid sequences present in said reaction mixture, wherein said active form of said tagged oligonucleotide has an available target hybridizing sequence for hybridization to said target region present in a non-target nucleic acid added to said reaction mixture, and wherein said reaction mixture does not comprise a nucleic acid polymerase capable of extending any of said oligonucleotides in a template-dependent manner.
Patent DK-2011862-T3 (DK)
Inventor: GREGERSEN JENS-PETER
IPC: C12N5/06
Filed: 2002-09-11
Granted: 2011-09-12
Abstract: Preparation of an active component (I) of a therapeutic or diagnostic agent by: (i) infecting Mandine-Darby canine kidney (MDCK) cells with a virus; and (ii) culturing the cells in suspension culture on a large scale (i.e. culture volume at least 30 l), so that viral replication occurs. An independent claim is also included for preparation of a therapeutic or diagnostic composition by formulating (I) prepared by the new method with adjuvants, auxiliaries, buffers, diluents or carriers. ACTIVITY : Virucide. No biological data given. MECHANISM OF ACTION : Vaccine.
Patent DK-2075726-T3 (DK)
Inventor: BOUVIER CHRISTIAN
IPC: G06K9/20
Filed: 2008-12-19
Granted: 2010-11-22
Abstract: The device (101) has a generation unit generating a message containing extract fields from information and emitting the message towards a certification server. A reception unit receives a certificate conforming to X.509standard, and calculated by the server by the fields and returned by the server. A communication unit communicates with a portable object, and a memory stores the certificate in the portable object. Another communication unit communicates a printer and a control device to reproduce information in the form of a code corresponding to the fields and the certificate. An independent claim is also included for a method for utilizing a semi-automatic and secured reading device for semi-automatic and secured reading of official paper e.g. national identity card, passport, cheque or bank card.
Patent DK-2250107-T3 (DK)
Inventor: PRESSLER ERIC M
IPC: B65G17/24
Filed: 2009-03-04
Granted: 2012-01-09
Abstract: Conveyors and methods for operating conveyors to accelerate laterally adjacent conveyed articles over different distances. The conveyors provide a conveying surface atop rollers in a conveyor belt. The belt rollers ride on a bearing surface underlying the belt on a carryway. As the belt advances, the rollers riding on the bearing surface rotate in a direction of rotation to accelerate conveyed articles along the belt in the direction of rotation. The bearing surface is shaped so that its length in the direction of belt travel varies across the width of the conveyor.
Patent DK-2271668-T3 (DK)
Inventor: RAHMAN SALMAN
IPC: C07K16/00
Filed: 2009-03-24
Granted: 2018-03-05
Abstract: The present invention relates to antibodies and antigen-binding fragments thereof, immunogenic peptide(s), and siRNA molecules which are capable of inhibiting neovascularization and/or angiogenesis and endothelial cell proliferation. The invention relates to antibodies and antigen-binding fragments thereof with specificity towards the metalloprotease domain of ADAM 15 and to immunogenic peptide(s) that elicits such antibodies. The invention also relates to compositions and kits comprising the antibodies and immunogenic peptide(s) of the invention, as well as methods and uses of the antibodies and antigen-binding fragments thereof and immunogenic peptide(s), as well as siRNA molecules.
Patent DK-2217787-T3 (DK)
Inventor: NIELSEN OTTO MARTINUS
IPC: E06C1/12
Filed: 2009-11-20
Granted: 2011-09-19
Abstract: A ladder having several collapsible ladder sections (100), each comprising two hollow ladder bars (102, 103) arranged parallel to each other and interconnected by a rung (104), where each collapsible ladder section is telescopically inserted into a lower ladder section. Each ladder bar of a collapsible ladder section has a locking hole (111) and an extension (112) below the locking hole. Retaining mechanisms (106) are provided in the rungs for locking the collapsible ladder sections relative to one another, and the retaining mechanisms comprise a locking pin (108), which can engage a corresponding locking hole provided in the ladder bar of a ladder section positioned there above. At least part of the collapsible ladder sections have a non-locking slot or groove (101) formed in the extensions of the ladder bars, where the slot reaches from a distance below the ladder bar to the bottom of the ladder bar. A ladder bar slot or groove may be positioned in such a way that a locking pin of a below lying ladder bar can pass freely in the slot of an above lying ladder section that is fully collapsed.
Patent DK-2389116-T3 (DK)
Inventor: WILLIAMSON WARREN P
IPC: A61B10/00
Filed: 2010-01-22
Granted: 2018-02-12
Abstract: Tissue orientation devices include a perforated tissue support with at least one perforated channel for receiving a tissue sample, and a plurality of tabs configured to extend along and into the channel to retain the tissue sample during processing and embedding. Tissue orientation devices include elongated legs coupled together for holding one or more biopsy tissue samples therebetween. Associated methods include using the cassettes and orientation devices to hold and orient tissue samples for processing, embedding and microtome sectioning.
Patent DK-2934864-T3 (DK)
Inventor: NIELSEN LARS
IPC: B29L31/08
Filed: 2013-12-18
Granted: 2018-07-16
Abstract: A wind turbine blade has a load carrying structure including at least a first spar cap and an aerodynamic shell having an outer surface forming at least part of an exterior surface of the wind turbine blade and an inner surface. The aerodynamic shell includes a first recess at the inner surface of the blade shell with a first thickened part at a first side of the first recess and a second thickened part at a second side of the first recess. The first recess is tapered towards the first side of the recess and tapered towards the second side of the recess, and the first spar cap is arranged in the first recess of the aerodynamic shell. The first spar cap is tapered towards a first side of the spar cap and further is tapered towards a second side of the spar cap.
Patent DK-0428169-T3 (DK)
Inventor: HONBO TOSHIYASU
IPC: A61K31/445
Filed: 1990-11-15
Granted: 1995-03-27
Abstract: An aqueous liquid formulation which comprises a compound of the formula : <CHEM> wherein the symbols define certain groups, particularly the compound 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methyl vinyl]-23, 25-dimethoxy-13,19,21,27-tetramethyl-11-28-dioxa-4-azatricyclo[22.3.2. 0<4,9</ SP>]octacos-18-ene-2,3,10,16-tetraone, and process for its preparation.
Patent DK-0391476-T3 (DK)
Inventor: HIUKE TAKASHI
IPC: A61F13/49
Filed: 1990-03-29
Granted: 1994-06-20
Abstract: A disposable absorbent article, such as a disposable diaper, having barrier leg cuffs. The barrier leg cuffs have a distal edge which is spaced from the proximal edge so as to provide a barrier against leakage. The barrier leg cuff has a portion affixed to the diaper so that the spacing between the barrier leg cuffs is increased in selected portions to reduce irritation of the genetalia and to provide a larger area to receive bodily discharges.
Patent DK-0391781-T3 (DK)
Inventor: LE MER JOSEPH
IPC: F24H1/52
Filed: 1990-04-02
Granted: 1992-07-13
Abstract: Double tube for a mixed boiler, comprising rectilinear segments in which the two sections of pipe are juxtaposed laterally. Each section (A, B) is delimited on the side furthest from the other section by a sheet (1, 7), the two longitudinal edges (2, 3, 8, 9) of which are curved and are welded against the longitudinal edges of an intermediate partition (4) and this intermediate partition has shaped bosses (5), the tops (6) of which are in contact with and joined to said sheets. 
<IMAGE>
Patent DK-0404672-T3 (DK)
Inventor: MERCIER CLAUDE
IPC: C07C45/65
Filed: 1990-06-20
Granted: 1993-10-25
Abstract: New terpene derivatives of general formula (I), their preparation and their use. In the general formula (I) R denotes a hydrogen atom or an alkanoyl radical and R' denotes a hydrogen atom or an aliphatic hydrocarbon radical optionally containing one or more double bonds. <IMAGE>
Patent DK-0536434-T3 (DK)
Inventor: HEILMANN ROLAND
IPC: F16L37/42
Filed: 1991-10-08
Granted: 1994-10-24
Abstract: A self-venting rapid connection-release coupling for pressurized gas lines, and in particular compressed air lines, has a coupling socket (1) and a coupling plug (2). The coupling socket is provided with two locking devices (22, 23) for the coupling plug (2), and these devices can be released in succession by a motion, in the same direction, of a slider sleeve (30) on the coupling socket (1). Moving the slider sleeve from a start or coupled position to an intermediate position, a first locking device (22) is released, but the slider sleeve (30) is arrested by a locking element (47), and the plug is held by the second locking device (23). The lockig element (47) is controlled as a function of the gas pressure in the coupling plug (2), until the gas pressure in the coupling plug (2) and the line to the severed compressed air line has been reduced by venting through venting conduits (51, 53). Only after the pressure has been released and vented, can the slider sleeve (30 ) be moved to a position permitting release of the coupling plug (2) from the socket (1).
Patent DK-0479359-T3 (DK)
Inventor: PEN JAN
IPC: C12N1/21
Filed: 1991-09-13
Granted: 1999-08-30
Abstract: The present invention provides plants with a modified taste, solids content and/or texture. The invention also provides methods of obtaining such plants via transformation with DNA constructs containing genes encoding enzymes capable of degrading plant polysaccharides and optionally additional genes encoding enzymes which are capable of further modifying the degradation products resulting from the first degradation step.
Patent DK-0470872-T3 (DK)
Inventor: RHA CHOKYUN
IPC: B01J13/10
Filed: 1991-08-12
Granted: 1994-11-14
Abstract: Use of degraded or reduced molecular weight polymers in encapsulation is disclosed. Short chain polysaccharide derivatives such as ionic cellulose derivative hydrolyzates are used in forming capsules by combining the short chain polysaccharide derivatives with another polymer. Substances designed to be encapsulated serve as nuclei around which coacervate droplets are formed. The short chain charged polymer includes degradation products of polysaccharide derivatives having an average degree of polymerization in the range of 3 to about 500. Methods of using capsules for delivering or storage of oils, and other substances are disclosed. The invention also discloses use of capsules in food, feed, pharmaceutical, cosmetic and personal care products and in the coating of paper with microscopic rupturable capsules containing printing fluid.
Patent DK-0482945-T3 (DK)
Inventor: STROLLE CHRISTOPHER H
IPC: G11B20/02
Filed: 1991-10-25
Granted: 1996-06-24
Abstract: A system is disclosed for recording and reproducing a luminance signal (Y) on and from a medium (40). The system includes an adaptive deemphasis circuit (10) for adaptively reducing the level of a high frequency portion of the luminance signal (Y). A record circuit records the reduced level luminance signal on the medium (40). A playback circuit reproduces the reduced level luminance signal from the medium (40). A reemphasis circuit (70) non-adaptively boosts the level of the high frequency portion of the reduced level luminance signal to produce the luminance signal (Y). To this end, a circuit (73) cores a high frequency portion of the reduced level luminance signal, and the level of the cored high frequency portion is then boosted by a predetermined amount to produce the luminance signal (Y). <MATH>
Patent DK-0519218-T3 (DK)
Inventor: SINGH MAHAVIR DR
IPC: C07K14/41
Filed: 1992-05-15
Granted: 1999-08-02
Abstract: The invention relates to a hybrid plasmid for the expression of an unfused 38 kDa antigen of Mycobacterium tuberculosis in E. coli, to E. coli as host of the hybrid plasmid and to the 38 kDa antigen. <IMAGE>
Patent DK-0542098-T3 (DK)
Inventor: WAGNER FRITZ PROF DR
IPC: C07B55/00
Filed: 1992-11-03
Granted: 2001-07-23
Abstract: 2.1. The chemical synthesis of amino acids produces a racemic mixture which can usually be fractionated by enzymatic cleavage. The remaining unwanted enantiomer is subsequently racemised anew and subjected again to racemate resolution. In the case of amino acids, this racemisation can easily be achieved in a temperature/time programme, but in the case of hydantoins the racemisation takes place in an acceptable time only for 5-arylhydantoins. The intention is therefore to provide a racemisation process for hydantoins which should be possible to carry out as simply as possible, i.e. without problematic foreign ions such as copper or additional compounds. 2.2. In the novel racemisation process, the enantiomer of a hydantoin which is monosubstituted in the 5 position is reacted in the presence of an ion exchanger. Anion exchangers are preferred, at a pH between 6.0 and 13.5. 2.3. Preparation of enantiomeric pure amino acids by enzymatic hydrolysis from 5-monosubstituted hydantoins.
Patent DK-0595851-T3 (DK)
Inventor: WILLIAMS MICHAEL TREVELYAN
IPC: C07C233/23
Filed: 1992-07-03
Granted: 1996-02-12
Abstract: PCT No. PCT/EP92/01496 Sec. 371 Date Jan. 10, 1994 Sec. 102(e) Date Jan. 10, 1994 PCT Filed Jul. 3, 1992 PCT Pub. No. WO93/01161 PCT Pub. Date Jan. 21, 1993.The invention provides the substantially geometrically and optically pure trans-stereoisomeric form of a compound of formula (I):     <IMAGE>  (I)  wherein R1 is H or C1-C4 alkyl, together with processes for its preparation. The compounds are intermediates for the preparation of the antidepressant agent known as sertraline.
Patent DK-0590382-T3 (DK)
Inventor: MOEST THOMAS DR
IPC: A61K9/16
Filed: 1993-09-10
Granted: 1996-08-26
Abstract: Method for producing pellets with a pronounced spherical structure, a particle size in the range from 0.1 to 4 mm and an apparent density above 0.5 g/cm<3>, which consist of 90 to 100 % by weight of an ephedrine derivative and of 0 to 10 % by weight of a pharmaceutical auxiliary, wherein the ephedrine derivative is suspended as powder with an average particle size of 0.5 to 50  mu m at 0 to 90 DEG C with stirring in a liquid which is a nonsolvent, is immiscible with water and has a boiling point in the range from 60 to 160 DEG C, 50 to 60 % by weight, based on the ephedrine derivative, of an agglomeration liquid are added with further stirring, the mixture is allowed to cool at 5 to 40 K per hour to -5 to 25 DEG C if it has previously been heated, with the stirring speed after the agglomeration of the powder particles being adjusted to a value necessary for the required pellet size, and the resulting pellets are separated and dried, and a pharmaceutical composition which contains such pellets, where appropriate with delayed release, as active ingredient.
Patent DK-0577281-T3 (DK)
Inventor: TROY EDWARD JOSEPH
IPC: C08L67/00
Filed: 1993-06-11
Granted: 2001-12-31
Abstract: Impact modifiers which produce transparent, high notched Izod impact strength blends with amorphous, aromatic polyesters are described. The impact modifiers are core-shell polymers with cores comprised mainly of rubbery polymers of diolefins and vinyl aromatic monomers and shells comprised mainly of styrene copolymers (e.g. styrene and hydroxyalkyl (meth)acrylate).
Patent DK-0602864-T3 (DK)
Inventor: GOLUNSKI STANISLAW EDMUND
IPC: C01B32/50
Filed: 1993-12-06
Granted: 2000-04-25
Abstract: A catalyst composed of metal oxide particles among which are uniformly incorporated, in order to reduce the operating temperature of the catalyst, palladium particles.